The PLAC Test, which measures Lp-PLA2, a vascular-specific - TopicsExpress



          

The PLAC Test, which measures Lp-PLA2, a vascular-specific inflammatory enzyme, is useful in predicting CHD risk . The PLAC test is approved by the FDA for the assessment of CHD and stroke risk in individuals with coronary atherosclerosis. After a median follow-up of 5 years, the study showed that individuals with Lp-PLA2 levels >225 nmol/min/mL had a CHD event rate of 7.0%, vs 3.3% for individuals with Lp-PLA2 levels
Posted on: Wed, 17 Dec 2014 11:08:42 +0000

Trending Topics



Recently Viewed Topics




© 2015